Publicacións nas que colabora con Ana Chopitea Ortega (12)

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

    European Journal of Cancer, Vol. 47, Núm. 6, pp. 839-847

  2. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

2010

  1. Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1529-1535

  2. Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab

    Critical Reviews in Oncology/Hematology, Vol. 74, Núm. 3, pp. 193-202

2009

  1. Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

    EJC SUPPLEMENTS

2007

  1. Combining chemotherapy and targeted therapies in metastatic colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5867-5876

  2. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What's new?

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5877-5887

  3. Histological response as potential prognostic factor after neoadjuvant chemotherapy (Ch) and chemoradiotherapy (CRT) for locally-advanced pancreatic cancer: preliminary results

    EJC SUPPLEMENTS

2006

  1. Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement

    Clinical and Translational Oncology, Vol. 8, Núm. 5, pp. 369-371

2005

  1. Assessment of the value of confirming responses in clinical trials in oncology

    European Journal of Cancer, Vol. 41, Núm. 11, pp. 1528-1532

  2. Capecitabine, oxaliplatin and irinotecan combination:: a first line treatment for metastasic colorectal cancer, preliminary results of a phase II study

    EJC SUPPLEMENTS